These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28282272)

  • 1. Role of Serum Soluble CD163 in the Diagnosis, Risk of Bleeding, and Prognosis of Gastro-Esophageal Varices in Cirrhotic Patients.
    Fouad R; Hamza I; Khairy M; Elsharkawy M; Helmy AA
    J Interferon Cytokine Res; 2017 Mar; 37(3):112-118. PubMed ID: 28282272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.
    Yang YY; Hou MC; Lin MW; Chen PH; Liao WC; Chu CJ; Lin HC
    J Gastroenterol Hepatol; 2013 Jan; 28(1):112-21. PubMed ID: 22849380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis.
    Waidmann O; Brunner F; Herrmann E; Zeuzem S; Piiper A; Kronenberger B
    J Hepatol; 2013 May; 58(5):956-61. PubMed ID: 23333526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.
    Eslam M; Ampuero J; Jover M; Abd-Elhalim H; Rincon D; Shatat M; Camacho I; Kamal A; Lo Iacono O; Nasr Z; Grande L; Banares R; Khattab MA; Romero-Gomez M
    Ann Hepatol; 2013; 12(4):588-98. PubMed ID: 23813137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
    Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
    Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis.
    Taher MY; El-Hadidi A; El-Shendidi A; Sedky A
    GE Port J Gastroenterol; 2022 Mar; 29(2):82-95. PubMed ID: 35497666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
    Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts.
    Kim BK; Ahn SH; Han KH; Park JY; Han MS; Jo JH; Kim JK; Lee KS; Chon CY; Kim DY
    Digestion; 2012; 86(3):264-72. PubMed ID: 22986832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Methods of Predicting Large Esophageal Varices in Children With Intrahepatic Portal Hypertension.
    Adami MR; Kieling CO; Schwengber FP; Hirakata VN; Vieira SMG
    J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):442-446. PubMed ID: 29176477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.
    Ibrahim EH; Marzouk SA; Zeid AE; Lashen SA; Taher TM
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):241-247. PubMed ID: 30281535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color Doppler ultrasonography is reliable in assessing the risk of esophageal variceal bleeding in patients with liver cirrhosis.
    Plestina S; Pulanić R; Kralik M; Plestina S; Samarzija M
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):711-7. PubMed ID: 16416372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study.
    Annicchiarico BE; Santonocito C; Siciliano M; Scapaticci M; Guarino D; Di Stasi C; Riccioni ME; Di Stasio E; Capoluongo E; Gasbarrini A
    Dig Liver Dis; 2019 Feb; 51(2):293-296. PubMed ID: 30236768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized trial: endoscopic follow up 3 vs 6 months after esophageal variceal eradication by band ligation in cirrhosis.
    Debernardi Venon W; Elia C; Stradella D; Bruno M; Fadda M; DeAngelis C; Rizzetto M; Saracco G; Marzano A
    Eur J Intern Med; 2014 Sep; 25(7):674-9. PubMed ID: 25018142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.
    Kayacetin E; Efe D; Doğan C
    J Gastroenterol; 2004 Jul; 39(7):661-7. PubMed ID: 15293137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients.
    Merkel C; Bolognesi M; Bellon S; Sacerdoti D; Bianco S; Amodio P; Gatta A
    J Hepatol; 1992 Jul; 15(3):299-303. PubMed ID: 1447495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal hypertension: pre-primary and primary prophylaxis of variceal bleeding.
    Tiani C; Abraldes JG; Bosch J
    Dig Liver Dis; 2008 May; 40(5):318-27. PubMed ID: 18291732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of first upper gastrointestinal bleeding using computerized tomoscanning in esophageal varices patients with cirrhosis and portal hypertension.
    Xie W; Chen FX; Zhu LY; Wen CC; Zhang X
    Medicine (Baltimore); 2020 Jan; 99(5):e18923. PubMed ID: 32000404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Variceal Bleeding Managed by Endoscopic Therapy in Patients with Cirrhosis.
    Rawal KK
    J Assoc Physicians India; 2016 Jun; 64(6):88-89. PubMed ID: 27739280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.